1. Zelen, M. (1997) Theory and practice of clinical trials, in Cancer Medicine ( Holland, J. F., et al., eds.), Williams and Wilkins, Baltimore, MD, pp. 423–436.
2. Holland, J. F., Frei, E., Kufe, D., and Bast, R. C. (1997) Principles of medical oncology, in Cancer Medicine ( Holland, J. F., et al., eds.), Williams and Wilkins, Baltimore, MD, pp. 755–765.
3. Labianca, R., Pancera, G., Dallavalle, G., Pessi, A., and Zamparelli, G. (1997) Response evaluation as the key-point in results interpretation. Tumori 83 (Suppl.), S73 — S76.
4. Frei, E. and Antman, K. (1997) Combination chemotherapy, dose and schedule, in Cancer Medicine ( Holland, J. F., et al., eds.), Williams and Wilkins, Baltimore, MD, pp. 817–838.
5. Motzer, R. J., Reed, E., Perera, F., Tang, D., Shamkhani, H., Poirier, M. C., et al. (1994) Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay. Cancer 73, 2843–2852.